Valion Bio Inc. is a late-stage immunotherapeutics company. It offers Entolimod, which is a drug used to treat acute radiation syndrome. Valion Bio Inc., formerly known as Tivic Health Systems Inc., is based in SAN ANTONIO, United States.
| Revenue (Most Recent Fiscal Year) | $0.78M |
| Net Income (Most Recent Fiscal Year) | $-8.88M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | -- |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 0.09 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -14936.05% |
| Net Margin (Trailing 12 Months) | -- |
| Return on Equity (Trailing 12 Months) | -193.17% |
| Return on Assets (Trailing 12 Months) | -67.10% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.11 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.86 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 1.74 |
| Inventory Turnover (Trailing 12 Months) | 0.00 |
| Book Value per Share (Most Recent Fiscal Quarter) | $166.26 |
| Earnings per Share (Most Recent Fiscal Quarter) | -- |
| Earnings per Share (Most Recent Fiscal Year) | -- |
| Diluted Earnings per Share (Trailing 12 Months) | -- |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Common Shares Outstanding | 0.89M |
| Free Float | 0.87M |
| Market Capitalization | $2.01M |
| Average Volume (Last 20 Days) | 0.50M |
| Beta (Past 60 Months) | 1.79 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 2.50% |
| Percentage Held By Institutions (Latest 13F Reports) | 4.25% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |